Skip to main content

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 217))

  • 94 Accesses

Abstract

Hypertrophic cardiomyopathy has intrigued clinicians since the condition was first described in eight patients by Donald Teare almost 40 years ago.1 The classic morphology of asymmetrical septal hypertrophy remains the most common form of the condition, but the increased availability of echocardiography, together with family and routine screening has demonstrated a diversity of cardiac phenotype.2–5 Patients may be profoundly disabled or asymptomatic,6 and presentation may occur at any age.7–9 Although the early studies focused on the classic form of the disease, the heterogeneity of the cardiac phenotype precludes a satisfactory definition, and diagnostic difficulty is relatively common. A working definition is to regard hypertrophic cardiomyopathy as an idiopathic condition characterised by a hypertrophied and non-dilated left and/or right ventricle in the absence of an identified cause such as hypertension or valvular heart disease.10,11 A positive family history greatly strengthens the diagnosis in uncertain cases.12,13

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 379.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Teare RD. Asymmetrical hypertrophy of the heart in young adults. Brit Heart J 1958: 20: 1.

    Article  PubMed  CAS  Google Scholar 

  2. Maron BJ, et al. Patterns and significance of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981: 48: 418.

    Article  PubMed  CAS  Google Scholar 

  3. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic car-diomuopathy: a two dimensional echocardiographic study. J Am Coll Cardiol 1983: 2: 437.

    Article  PubMed  CAS  Google Scholar 

  4. McKenna W, et al. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981: 47: 532.

    Article  PubMed  CAS  Google Scholar 

  5. Maron BJ, et al. How common is hypertrophic cardiomyopathy? Echocardiographically identified prevalance in a general population of young adults. (The CARDIA Study). Circulation 1993: 88: 211.

    Google Scholar 

  6. Spirito P, et al. Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localised left ventricular hypertrophy. J Am Coll Cardiol 1986: 8: 537.

    Article  PubMed  CAS  Google Scholar 

  7. Spirito P, Maron BJ. realtion between of left ventricular hypertrophy and age in hypertrophic cardiomyopathy. J Am Coll Cardiol 1989: 13: 820.

    Article  PubMed  CAS  Google Scholar 

  8. Lewis JF, Maron BJ. clinical and morphologic expression of hypertrophic cardiomyopathy in patients> or = 65 years of age. Am J Cardiol 1994: 73: 1105.

    Article  PubMed  CAS  Google Scholar 

  9. Pomerance A, Davies MJ. Patholical features of hypertrophic obstructive cardiomyopathy (HOCM) in the elderly. Brit Heart J 1975: 37: 305.

    Article  PubMed  CAS  Google Scholar 

  10. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979: 43: 1242.

    Article  PubMed  CAS  Google Scholar 

  11. Report of the WHO/IFSC task force on the definition and classification of cardiomyopathies. Brit Heart J 1980: 44: 672.

    Article  Google Scholar 

  12. Greaves SC, et al. Inheritance of hypertrophic cardiomyopathy: a cross-sectional and M-mode study of 50 families. Brit Heart J 1987: 58: 259.

    Article  PubMed  CAS  Google Scholar 

  13. Maron BJ, et al. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 1984: 53: 1087.

    Article  PubMed  CAS  Google Scholar 

  14. Lewis JF, et al. Usefulness of Doppler echocardiographic assessment of diastolic filling in distinguishing“athlete’s heart”from hypertrophic cardiomyopathy. Br Heart J 1992: 68: 296.

    Article  PubMed  CAS  Google Scholar 

  15. Cousineau D, et al. Catecholamines in coronary sinus during exrecise in man before and after training. J Appl Physiol 1977: 43: 801.

    PubMed  CAS  Google Scholar 

  16. Coplan NL, et al. Exercise-related changes in serum catecholamines and potassium: effect of sustained exercise above and below lactate threshold. Am Heart J 1989: 117: 1070.

    Article  PubMed  CAS  Google Scholar 

  17. Lehman M, et al. Plasma catecholamines in trained and untrained volunteers during graduated exercise. Int J Sports Med 1981: 2: 143.

    Article  Google Scholar 

  18. McKenna WJ, et al. Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 1990: 63: 287.

    Article  PubMed  CAS  Google Scholar 

  19. Watkins H, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992: 326: 1108.

    Article  PubMed  CAS  Google Scholar 

  20. Epstein ND, et al. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu—> Val mutation and a 403Arg—> Gln mutation. Circulation 1992: 86: 345.

    Article  PubMed  CAS  Google Scholar 

  21. Hengstenberg C, Schwartz K. Molecular genetics of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 1994: 26: 3.

    Article  PubMed  CAS  Google Scholar 

  22. McKenna WJ, et al. Sudden death in hypertrophic cardiomyopathy: Identification and management of high risk patients. In: Advances in cardiomyopathies. Baroldi G, Camerini F, Goodwin JF. eds. Springer-Verlag, Berlin, 1990: 72.

    Chapter  Google Scholar 

  23. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation 1994: 89: 22.

    Article  PubMed  CAS  Google Scholar 

  24. Hengstenberg C, et al. Clinical and genetical heterogeneity of familial hypertrophic cardiomyopathy. Herz 1994: 19: 84.

    PubMed  CAS  Google Scholar 

  25. Solomon SD, et al. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene. J Am Coll Cardiol 1993: 22: 498.

    Article  PubMed  CAS  Google Scholar 

  26. Anan R, et al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994: 93: 280.

    Article  PubMed  CAS  Google Scholar 

  27. Davies MJ. the current status of myocardial disarray in hypertrophic cardiomyopathy. Brit Heart J 1984: 51: 361.

    Article  PubMed  CAS  Google Scholar 

  28. Maron BJ, et al. Realtion between extent of cardiac muscle cell disorganization and left ventricular wall thickness in hypertrophic cardiomyopathy. Am J Cardiol 1192: 70: 785.

    Google Scholar 

  29. Kuck KH, et al. Programmed electrical stilmulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or synopse. Eur Heart J 1988: 9: 177.

    PubMed  CAS  Google Scholar 

  30. Fananapazir L, et al. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic and electrophysiological findings. Circulation 1992: 86: 730.

    Article  PubMed  CAS  Google Scholar 

  31. Fananapazir L, Epstein SE. value of electrophysiologic studies in hypertrophic cardiomyopathy. Am J Cardiol 1191: 67: 175.

    Google Scholar 

  32. Saumarez RC, et al. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation 1992: 86: 467.

    Article  PubMed  CAS  Google Scholar 

  33. Lefroy DC, et al. Diffuse reduction of myocardial beta-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol 1993: 22: 1653.

    Article  PubMed  CAS  Google Scholar 

  34. Davies MJ, Krikler DM. Genetic investigation and counselling of families with hypertrophic cardiomyopathy. Br Heart J 1994, 72: 99.

    Article  PubMed  CAS  Google Scholar 

  35. Al Mahdawi S, et al. The electrogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J 1994: 72: 105.

    Article  Google Scholar 

  36. Ryan MP, et al. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 1995: 17: 452.

    Google Scholar 

  37. Maron BJ, et al. Development or progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy: identification by two-dimensional echocardiography. New Engl J Med 1986: 315: 610.

    Article  PubMed  CAS  Google Scholar 

  38. Panza JA, et al. Development and determinants of dynamic obstructions to left ventricular outflow in young patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1989: 13: 820.

    Article  Google Scholar 

  39. Spirito P, Maron BJ. Absence of progression of left ventricular hypertrophy in adult patients with hypertrophic cardiomyopathy. Am J Cardiol 1987: 9: 1013.

    Article  CAS  Google Scholar 

  40. Spirito P, et al. Occurence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol 1987: 60: 123.

    Article  PubMed  CAS  Google Scholar 

  41. Maron BJ, et al. Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study. Am J Cardiol 1994: 73: 577.

    Article  PubMed  CAS  Google Scholar 

  42. Bohn M, et al. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 44: 298.

    Google Scholar 

  43. Schunkert H, et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994: 330: 1634.

    Article  PubMed  CAS  Google Scholar 

  44. Marian AJ, et al. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993: 342: 1085.

    Article  PubMed  CAS  Google Scholar 

  45. Schunkert H, Paul M. Cardiac angiotensin converting enzyme and diastolic function of the heart. Agents Actions Suppl 38: 119.

    Google Scholar 

  46. Kofflard MJ, et al. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol 1993: 72: 939.

    Article  PubMed  CAS  Google Scholar 

  47. Maron BJ, Fananapazir L. Sudden cardiac death in hypertrophic cardiomyopathy. Circulation 1992: 85: 157.

    Google Scholar 

  48. Maron BJ, et al. Prognostic significance of 24-hour ambulatory monitoring in patients with hypertrophic cardiomyopathy. Am J Cardiol 1981: 48: 252.

    Article  PubMed  CAS  Google Scholar 

  49. Frenneaux P, et al. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation 1991: 82: 1995.

    Article  Google Scholar 

  50. McKenna WJ, et al. Syncope in hypertrophic cardiomyopathy. Brit Heart J 1982: 47: 177.

    Article  PubMed  CAS  Google Scholar 

  51. Counihan PJ, et al. Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy. Circulation 1991: 84: 686.

    Article  PubMed  CAS  Google Scholar 

  52. Nihoyannopoulos P, et al. Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol 1992: 19: 536.

    Article  PubMed  CAS  Google Scholar 

  53. Messmer BJ. Extended myectomy for hypertrophic obstructive cardiomyopathy. Am Thorac Surg 1994: 58: 575.

    Article  CAS  Google Scholar 

  54. Delahaye F, et al. Postoperative and long-term prognosis of myotomy-myomectomy for obstructive hypertrophic cardiomyopathy: influence of associated mitral valve replacement. Eur Heart J 1993: 14: 1229.

    Article  PubMed  CAS  Google Scholar 

  55. Stone CD, et al. Operative treatment of pediatric obstructive hypertrophic cardiomyopathy: a 26-year experience. Ann thorac Surg 1993: 56: 1308.

    Article  PubMed  CAS  Google Scholar 

  56. Wagner JA, et al. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy. N Engl J Med 1989: 320: 755.

    Article  PubMed  CAS  Google Scholar 

  57. Doiuchi J, et al. Comparative effects of calcium-channel blockers and beta-adrenergic blocker on early diastolic time intervals and A-wave ratio in patients with hypertrophic cardiomyopathy. Clin Cardiol 1987: 10: 26.

    Article  PubMed  CAS  Google Scholar 

  58. Gilligan DM, et al. A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy. J Am Coll Cardiol 1993: 21: 1672.

    Article  PubMed  CAS  Google Scholar 

  59. Fananapazir L, et al. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symproms refractory to verapamil and beta-adrenergic blocker therapy. Circulation 1992: 85: 2149.

    Article  PubMed  CAS  Google Scholar 

  60. Jeanrenaud X, et al. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992: 339: 1318.

    Article  PubMed  CAS  Google Scholar 

  61. McAreavey D, Fananapazir L. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy. Am J Cardiol 70: 651.

    Google Scholar 

  62. Cannon RO, et al. Results of permanent dual-chamber pacing in sympromatic nonobstructive hypertrophic cardiomyopathy. Am J Cardiol 1994: 73: 571.

    Article  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dutka, D.P., Oakley, C.M. (1999). Hypertrophic Cardiomyopathy. In: Contemporary Concepts in Cardiology. Developments in Cardiovascular Medicine, vol 217. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5007-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5007-5_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7274-5

  • Online ISBN: 978-1-4615-5007-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics